Fung-Kee-Fung M - Search Results

1

OV21/PETROC: a randomized Gynecologic Cancer Intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer.

Provencher DM, Gallagher CJ, Parulekar WR, Ledermann JA, Armstrong DK, Brundage M, Gourley C, Romero I, Gonzalez-Martin A, Feeney M, Bessette P, Hall M, Weberpals JI, Hall G, Lau SK, Gauthier P, Fung-Kee-Fung M, Eisenhauer EA, Winch C, Tu D, MacKay HJ. Provencher DM, et al. Ann Oncol. 2018 Feb 1;29(2):431-438. doi: 10.1093/annonc/mdx754. Ann Oncol. 2018. PMID: 29186319 Free PMC article. Clinical Trial.

2

The role of topotecan as second-line therapy in patients with recurrent ovarian cancer.

Beshara N, Fung Kee Fung M, Faught W. Beshara N, et al. Eur J Gynaecol Oncol. 2002;23(4):287-90. Eur J Gynaecol Oncol. 2002. PMID: 12214724

3

Primary chemotherapy and adjuvant tumor debulking in the management of advanced-stage epithelial ovarian cancer.

Le T, Faught W, Hopkins L, Fung Kee Fung M. Le T, et al. Int J Gynecol Cancer. 2005 Sep-Oct;15(5):770-5. doi: 10.1111/j.1525-1438.2005.00134.x. Int J Gynecol Cancer. 2005. PMID: 16174222 Free article.

4

Quality of life assessments in epithelial ovarian cancer patients during and after chemotherapy.

Le T, Hopkins L, Fung Kee Fung M. Le T, et al. Int J Gynecol Cancer. 2005 Sep-Oct;15(5):811-6. doi: 10.1111/j.1525-1438.2005.00141.x. Int J Gynecol Cancer. 2005. PMID: 16174229 Free article.

5

Prognostic significance of tumor necrosis in ovarian cancer patients treated with neoadjuvant chemotherapy and interval surgical debulking.

Le T, Shahriari P, Hopkins L, Faught W, Fung Kee Fung M. Le T, et al. Int J Gynecol Cancer. 2006 May-Jun;16(3):986-90. doi: 10.1111/j.1525-1438.2006.00594.x. Int J Gynecol Cancer. 2006. PMID: 16803473

6

Intraperitoneal chemotherapy for advanced epithelial ovarian cancer: A Canadian perspective.

Alhayki M, Hopkins L, LE T, Fung Kee Fung M. Alhayki M, et al. Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1761-5. doi: 10.1111/j.1525-1438.2006.00713.x. Int J Gynecol Cancer. 2006. PMID: 17009968

7

Intraperitoneal chemotherapy for patients with advanced ovarian cancer: a review of the evidence and standards for the delivery of care.

Fung-Kee-Fung M, Provencher D, Rosen B, Hoskins P, Rambout L, Oliver T, Gotlieb W, Covens A; IP Chemotherapy Working Group/Society of Gynecologic Oncologists of Canada. Fung-Kee-Fung M, et al. Gynecol Oncol. 2007 Jun;105(3):747-56. doi: 10.1016/j.ygyno.2007.02.015. Epub 2007 Mar 21. Gynecol Oncol. 2007. PMID: 17368522

8

The lack of significance of Ca125 response in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking.

Le T, Hopkins L, Faught W, Fung-Kee-Fung M. Le T, et al. Gynecol Oncol. 2007 Jun;105(3):712-5. doi: 10.1016/j.ygyno.2007.02.022. Epub 2007 Apr 2. Gynecol Oncol. 2007. PMID: 17400284

9

The definition of optimal inguinal femoral nodal dissection in the management of vulva squamous cell carcinoma.

Le T, Elsugi R, Hopkins L, Faught W, Fung-Kee-Fung M. Le T, et al. Ann Surg Oncol. 2007 Jul;14(7):2128-32. doi: 10.1245/s10434-007-9417-5. Epub 2007 May 2. Ann Surg Oncol. 2007. PMID: 17473950

10

Histopathologic assessment of chemotherapy effects in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking.

Le T, Williams K, Senterman M, Hopkins L, Faught W, Fung-Kee-Fung M. Le T, et al. Gynecol Oncol. 2007 Jul;106(1):160-3. doi: 10.1016/j.ygyno.2007.03.029. Epub 2007 May 9. Gynecol Oncol. 2007. PMID: 17490737

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page